We’re now deep into flu season here in the U.S., and word of respiratory infection cases increasing in China might bring people memories of early 2020. However, public health officials say there isn’t a reason to panic.

The WHO said Chinese data up to Dec 29 showed detections of HMPV, seasonal influenza, rhinovirus, and respiratory syncytial virus (RSV) have all increased in recent weeks, particularly in northern parts of China. Influenza is currently the most commonly reported cause of disease, it said.

The human metapneumovirus is reportedly surging in China, but should Americans be concerned? Here's what to know about HMPV symptoms and more.

While cases are climbing in China, the situation is very different from what it was when Covid-19 emerged five years ago, medical experts say. HMPV has circulated in humans for decades.

As China continues to monitor an increase in cases of human metapneumovirus (HMPV), here's what you need to know about the illness.

Experts say China's rise in HMPV cases is “consistent with global patterns”. But how does the disease compare to COVID-19 and how can we protect ourselves?

Authorities in Beijing have downplayed surge in cases, which comes five years after world was first alerted to emergence of Covid-19

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

India confirmed its first cases of human metapneumovirus (HMPV) infections in children, with a total of seven cases reported as of Tuesday. The cases were reported in Bengaluru, Nagpur, Tamil Nadu and Ahmedabad,